Cassandra Rae Duffy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometritis | 3 | 2022 | 49 | 1.670 |
Why?
|
Antibiotic Prophylaxis | 5 | 2022 | 640 | 1.370 |
Why?
|
Delivery, Obstetric | 8 | 2021 | 953 | 1.370 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2024 | 2181 | 0.910 |
Why?
|
Cesarean Section | 3 | 2022 | 1414 | 0.860 |
Why?
|
Povidone-Iodine | 2 | 2020 | 56 | 0.840 |
Why?
|
Collagen Type I | 1 | 2024 | 620 | 0.730 |
Why?
|
Premature Birth | 2 | 2024 | 1816 | 0.720 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 134 | 0.660 |
Why?
|
Clindamycin | 1 | 2020 | 139 | 0.660 |
Why?
|
Gentamicins | 1 | 2020 | 245 | 0.630 |
Why?
|
Lymphopenia | 1 | 2020 | 290 | 0.600 |
Why?
|
Obstetrics | 3 | 2020 | 676 | 0.600 |
Why?
|
Surgical Wound Infection | 3 | 2022 | 1544 | 0.590 |
Why?
|
Pregnancy | 20 | 2024 | 30179 | 0.560 |
Why?
|
Vagina | 2 | 2019 | 845 | 0.540 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 248 | 0.540 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 243 | 0.530 |
Why?
|
Methadone | 1 | 2018 | 322 | 0.520 |
Why?
|
Streptococcal Infections | 1 | 2020 | 619 | 0.500 |
Why?
|
Standard of Care | 1 | 2019 | 571 | 0.470 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2019 | 518 | 0.460 |
Why?
|
Clostridium Infections | 1 | 2020 | 559 | 0.420 |
Why?
|
Tocolytic Agents | 1 | 2012 | 24 | 0.410 |
Why?
|
Fetal Monitoring | 1 | 2012 | 70 | 0.400 |
Why?
|
Magnesium Sulfate | 1 | 2012 | 73 | 0.390 |
Why?
|
Heart Rate, Fetal | 1 | 2012 | 76 | 0.390 |
Why?
|
Buprenorphine | 1 | 2018 | 661 | 0.360 |
Why?
|
Preoperative Care | 1 | 2019 | 2257 | 0.340 |
Why?
|
Pregnancy Outcome | 2 | 2018 | 2959 | 0.340 |
Why?
|
Anti-Bacterial Agents | 4 | 2022 | 7471 | 0.330 |
Why?
|
Labor, Obstetric | 1 | 2012 | 323 | 0.320 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1943 | 0.280 |
Why?
|
Zambia | 2 | 2024 | 273 | 0.270 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1884 | 0.250 |
Why?
|
Analgesics, Opioid | 2 | 2019 | 3837 | 0.250 |
Why?
|
Maternal Exposure | 1 | 2012 | 1078 | 0.240 |
Why?
|
Syphilis Serodiagnosis | 1 | 2024 | 37 | 0.230 |
Why?
|
Bone Diseases, Developmental | 1 | 2024 | 132 | 0.220 |
Why?
|
Hospitalization | 6 | 2020 | 10845 | 0.220 |
Why?
|
Preconception Care | 1 | 2024 | 143 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Chorion | 1 | 2021 | 112 | 0.190 |
Why?
|
Infant, Small for Gestational Age | 1 | 2024 | 464 | 0.190 |
Why?
|
Syphilis | 1 | 2024 | 243 | 0.190 |
Why?
|
HIV Infections | 2 | 2024 | 17564 | 0.180 |
Why?
|
Female | 21 | 2024 | 396943 | 0.170 |
Why?
|
Placenta, Retained | 1 | 2019 | 22 | 0.170 |
Why?
|
Fatal Outcome | 1 | 2024 | 1840 | 0.170 |
Why?
|
Uterine Balloon Tamponade | 1 | 2019 | 37 | 0.160 |
Why?
|
Chlorhexidine | 1 | 2020 | 160 | 0.160 |
Why?
|
Labor Presentation | 1 | 2018 | 55 | 0.160 |
Why?
|
Infant, Newborn | 4 | 2024 | 26395 | 0.150 |
Why?
|
Perineum | 1 | 2019 | 210 | 0.150 |
Why?
|
Streptococcus agalactiae | 1 | 2020 | 338 | 0.150 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.150 |
Why?
|
Term Birth | 1 | 2018 | 140 | 0.150 |
Why?
|
Lacerations | 1 | 2019 | 149 | 0.150 |
Why?
|
Azithromycin | 1 | 2019 | 200 | 0.150 |
Why?
|
Vancomycin | 1 | 2020 | 506 | 0.140 |
Why?
|
Adult | 13 | 2024 | 223542 | 0.140 |
Why?
|
Drug Utilization | 2 | 2019 | 1192 | 0.130 |
Why?
|
Young Adult | 8 | 2024 | 60045 | 0.130 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2015 | 66 | 0.120 |
Why?
|
Viral Load | 1 | 2024 | 3399 | 0.120 |
Why?
|
Humans | 21 | 2024 | 768451 | 0.120 |
Why?
|
Opiate Substitution Treatment | 1 | 2018 | 446 | 0.110 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2022 | 1903 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1359 | 0.100 |
Why?
|
Gestational Age | 1 | 2021 | 3615 | 0.100 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 424 | 0.100 |
Why?
|
Gynecological Examination | 1 | 2012 | 32 | 0.100 |
Why?
|
Risk Factors | 3 | 2024 | 74915 | 0.090 |
Why?
|
Income | 1 | 2018 | 1878 | 0.090 |
Why?
|
Linear Models | 1 | 2020 | 5880 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2020 | 2780 | 0.080 |
Why?
|
Length of Stay | 1 | 2022 | 6521 | 0.080 |
Why?
|
Anti-HIV Agents | 1 | 2024 | 4567 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2239 | 0.080 |
Why?
|
Patient Readmission | 1 | 2022 | 3308 | 0.070 |
Why?
|
Adolescent | 6 | 2020 | 89168 | 0.070 |
Why?
|
Prospective Studies | 2 | 2024 | 54914 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13324 | 0.070 |
Why?
|
Databases, Factual | 2 | 2020 | 8081 | 0.070 |
Why?
|
Developing Countries | 1 | 2018 | 2901 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7863 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1622 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2022 | 22293 | 0.060 |
Why?
|
Treponema pallidum | 1 | 2024 | 48 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5096 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3463 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2040 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3104 | 0.050 |
Why?
|
Pre-Eclampsia | 1 | 2012 | 1257 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26351 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20231 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2022 | 607 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2022 | 81834 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4083 | 0.040 |
Why?
|
United States | 4 | 2020 | 73121 | 0.040 |
Why?
|
Codeine | 1 | 2019 | 51 | 0.040 |
Why?
|
Tramadol | 1 | 2019 | 63 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6400 | 0.040 |
Why?
|
Pregnant Women | 1 | 2022 | 576 | 0.030 |
Why?
|
Models, Organizational | 1 | 2020 | 546 | 0.030 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2019 | 15880 | 0.030 |
Why?
|
Insurance, Health | 2 | 2019 | 2513 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1596 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15965 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 4041 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2526 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2012 | 577 | 0.020 |
Why?
|
Mass Screening | 1 | 2024 | 5455 | 0.020 |
Why?
|
Middle Aged | 2 | 2020 | 223418 | 0.020 |
Why?
|
Brachytherapy | 1 | 2015 | 1227 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 65409 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3858 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12875 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9642 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36497 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39430 | 0.010 |
Why?
|
Aged | 1 | 2015 | 171520 | 0.000 |
Why?
|